Advance your Phase I Trial

Clinical Research Units (CRUs)

Gain the critical data needed to make earlier and more confident decisions by leveraging our global network of clinical research units (CRUs). Our integrated approach manages the complexity of Phase I trials in healthy volunteers, patients and special populations.

Managing the complexity of early-phase clinical trials

Advance your Phase I trial at one of our four clinical research units (CRUs) strategically based in the U.S. and the U.K. These state-of-the-art facilities provide everything you need to advance complex research while promoting participant well-being.

Leeds Drapers Yard, U.K.

Our recently built, sustainably designed CRU in Leeds Drapers Yard combines our two former locations with 100 beds, a cGMP pharmacy, including two sterile and two non-sterile rooms, and increase capacity for ECG and telemetry Holter monitoring.  

Clinical Research Unit Overview cGMP Pharmacy Overview

Daytona Beach, Florida

Encompassing an estimated population of more than 21 million people, our Daytona Beach clinical pharmacology unit offers extensive experience with a range of trials spanning FIH bioequivalence, bioavailability, definitive QTc, drug-drug interaction, proof-of-concept, rising dose and Phase IIa patient studies.

Clinical Research Unit Overview cGMP Pharmacy Overview

Madison, Wisconsin

Our Madison clinical pharmacology unit is regarded as the global leader in the conduct of radiolabeled clinical studies. The site also includes a cGMP pharmacy, including two sterile and three non-sterile manufacturing suites.

Dallas, Texas

With a dedicated ophthalmology suite and a cGMP pharmacy, including two sterile and three non-sterile manufacturing suites that can manage and handle high-potency and hazardous drugs, our Dallas clinical pharmacology unit can support inpatient and outpatient Phase I-IV clinical trials of investigational medications.